IRDye800-H-ferritin nanocarrier (IRDye800-HFn) (Jia et al., 2020) was applied in imaging hypoxia in glioma, and albumin-based gold (Au) NP, ICG/AuNR@BCNP, was used as theranostics for glioma- and hypoxia-alleviating treatment (Yang et al., 2020). The gene discussed is FTH1; the disease is central nervous system cancer.